A Comprehensive Literature Review of Treatment-Emergent Integrase Resistance with Dolutegravir-Based Regimens in Real-World SettingsCassidy Henegar, Vani Vannappagari, Emilio Letang et al.|Viruses|2023Cited by 13
Efficacy and safety of switching to dolutegravir/lamivudine in virologically suppressed people with HIV-1 aged ≥ 50 years: week 48 pooled results from the TANGO and SALSA studiesSharon Walmsley, Mounir Ait‐Khaled, Richard Grove et al.|AIDS Research and Therapy|2024Cited by 11
Role of Dolutegravir/Lamivudine in the Management of Pregnant People Living with HIV-1: A Narrative ReviewWilliam R. Short, Bryn Jones, Parul Patel et al.|Infectious Diseases and Therapy|2024Cited by 5
Efficacy and Safety of DTG/3TC for Prophylaxis of HIV Perinatal Transmission: A Pilot Study (PREGNANCY)Carlos Brites, Ana Gabriela Travassos, Bryn Jones et al.|Open Forum Infectious Diseases|2024Cited by 2